The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 TRIDENT study (EF-32): Tumor treating fields (TTFields; 200 kHz) concomitant with chemoradiation, and maintenance TTFields therapy/temozolomide in newly diagnosed glioblastoma.
 
Wenyin Shi
Consulting or Advisory Role - Brainlab; Novocure; Varian Medical Systems; Zai lab
Research Funding - BrainLAB (Inst); Novocure (Inst); Regeneron (Inst)
 
David Roberge
Stock and Other Ownership Interests - Arctic Fox AI; Croton Healthcare; Miso Chip
Honoraria - Accuray; Bayer; BrainLAB; Kyowa Kirin; Pfizer/EMD Serono; Roche Canada; Siemens Healthineers; ZAP Surgical
Consulting or Advisory Role - Novocure; Precirix; Recordati
Research Funding - Bristol-Myers Squibb (Inst); Elekta (Inst); Siemens Healthineers (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Accuray
 
Lawrence Kleinberg
Consulting or Advisory Role - Novocure
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Incyte; Novartis (Inst)
 
Suriya A. Jeyapalan
Consulting or Advisory Role - Novocure
Speakers' Bureau - Novocure
 
Samuel Aaron Goldlust
Employment - Regional Cancer Care Associates
Leadership - Cellevolve
Stock and Other Ownership Interests - COTA
Honoraria - Cornerstone Specialty Network; Daiichi Sankyo/Astra Zeneca; Physicans' Education Resource
Consulting or Advisory Role - Boston Biomedical; Cellevolve; Cornerstone Specialty Network; Daiichi Sankyo/Astra Zeneca; Novocure; Sumitomo Dainippon Pharma Oncology
Speakers' Bureau - Novocure
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); AlgoTX (Inst); Amgen (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Candel Therapeutics (Inst); Cantex Pharmaceuticals (Inst); Celgene (Inst); Celldex (Inst); Celularity (Inst); CNS Healthcare (Inst); Cortice Biosciences (Inst); Diffusion Pharmaceuticals (Inst); Epitopoietic Research Corporation (Inst); ImmunoCellular Therapeutics (Inst); Imvax (Inst); Imvax (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Merck (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst); Novogen (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Sumitomo Dainippon Pharma Oncology (Inst); Tocagen (Inst); Veloxis (Inst); Wex Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Novocure
 
Seema Nagpal
Consulting or Advisory Role - Biocept; Mirati Therapeutics; Novocure; Nurix; Pyramid Biosciences; Seagen
Research Funding - Agios (Inst); Berg Pharma (Inst); Inovio Pharmaceuticals (Inst); PharmAbcine (Inst)
 
Leonardo Lustgarten
Employment - Novocure
Stock and Other Ownership Interests - Novocure
 
Stephanie E Combs
Consulting or Advisory Role - Accuray; AstraZeneca; Brainlab; Bristol Myers Squibb Foundation; Daiichi Sankyo Pharmaceutical; Dr. Sennewald Medizintechnik; Elekta; Icotec; Medac; Roche
Research Funding - Deutsche Forschungsgemeinschaft
 
Ryo Nishikawa
Honoraria - Nippon Kayaku
Speakers' Bureau - Eisai; Ono Pharmaceutical
Research Funding - Chugai Pharma
Other Relationship - Novocure
 
David A. Reardon
Honoraria - Advantagene; Agenus; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Deciphera; DelMar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kintara Therapeutics; KIYATEC; Medicenna; Merck; Merck KGaA; NEUVOGEN; Novocure; Oncorus; Regeneron; Sumitono Dainippon Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Vivacitas Oncology; Y-mAbs Therapeutics
Consulting or Advisory Role - Advantagene; Agenus; Agios; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Kintara Therapeutics; Kiyatec; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical; Vivacitas Oncology
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Enterome (Inst); Incyte (Inst); Omniox
 
Rachel Grossman
Honoraria - Zai Lab
Travel, Accommodations, Expenses - Novocure
 
Martin Glas
Honoraria - Kyowa Kirin; medac Pharma; Merck; Novartis; Novocure
Consulting or Advisory Role - Bayer; Daiichi Sankyo Pharmaceutical; Janssen-Cilag; Novartis; Novocure; Roche
Travel, Accommodations, Expenses - Novocure